WNT & B-Catenin Targeted Drug Development Summit

Following the exciting clinical updates from Leap Therapeutics, Tonix Pharmaceuticals, and Iterion, we are pleased to bring the 2nd Wnt/B-Catenin Targeted Drug Development Summit back in 2023 as an in-person meeting to Boston.As the only industry-led meeting focusing on this complex pathway, we will unite Wnt/β-catenin drug developers and pioneers to share their lessons learned, and how to translate structural biology into clinical development, and overcome the safety and toxicity concerns.This 3-days summit in January will arm you with the success stories, and top tips from your industry peers to modulate Wnt/β-catenin pathways in immuno-oncology to meet unmet medical needs – and offer efficacious treatments for patients!Be part of this conversation and take a look at your complimentary agenda to learn about the unmissable case studies.